2月25日 - ** Organovo Holdings ONVO.O的股价盘前上涨两倍多，达到1.35美元
** ONVO称 (link)，它正在向礼来LLY.N出售其FXR项目，包括主要资产FXR314。
** ONVO的FXR项目专注于开发治疗炎症性肠病的新方法
** 根据协议，礼来公司将向 ONVO 支付 1,000 万美元的预付款，如果未来达到某些里程碑，则支付 5,000 万美元。
** LLY 将获得 Organovo FXR 项目的所有商业和知识产权，用于全球开发。
** ONVO 表示，收购将使礼来公司能够从中期阶段开始进一步开发 FXR314
** 2024 年，ONVO 下跌约 68
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.